Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Chiara M. Eandi"'
Autor:
Emilien Seiler, Léon Delachaux, Jennifer Cattaneo, Ali Garjani, Thibaud Martin, Alexia Duriez, Jérémy Baffou, Sepehr Mousavi, Ilenia Meloni, Ciara Bergin, Mattia Tomasoni, Chiara M. Eandi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Central serous chorioretinopathy (CSCR) is a retinal disease characterised by the accumulation of subretinal fluid, which often resolves spontaneously in acute cases. However, approximately one-third of patients experience recurrences that m
Externí odkaz:
https://doaj.org/article/77b22f21b8ad4bd18f121061b570720c
Autor:
Justus G. Garweg, Claudine A. Blum, René-Pierre Copt, Chiara M. Eandi, Katja Hatz, Christian F. Prünte, Eleonora Seelig, Gábor M. Somfai
Publikováno v:
Ophthalmology and Therapy, Vol 12, Iss 2, Pp 639-655 (2023)
Abstract Anti-vascular endothelial growth factor (anti-VEGF) therapies have become the standard of care in the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME), resulting in a remarkable decrease in di
Externí odkaz:
https://doaj.org/article/4cee70aabcf3434a960a2f9ca42ceb75
Autor:
Salvatore Giunta, Agata Grazia D’Amico, Grazia Maugeri, Claudio Bucolo, Giovanni Luca Romano, Settimio Rossi, Chiara M. Eandi, Elisabetta Pricoco, Velia D’Agata
Publikováno v:
Pharmaceuticals, Vol 16, Iss 7, p 974 (2023)
In the area of drug discovery, repurposing strategies represent an approach to discover new uses of approved drugs besides their original indications. We used this approach to investigate the effects of dimethyl fumarate (DMF), a drug approved for re
Externí odkaz:
https://doaj.org/article/6153f98b90534d1cb628e6329bcf6a0c
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/f52e97aeaed74769a6cbc3a96c34f169
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
To report the early efficacy and safety outcomes of treatment with intravitreal injections of brolucizumab (IVT-B) in patients presenting neovascular age-related macular degeneration (nAMD) in a tertiary clinical setting. A retrospective case series
Externí odkaz:
https://doaj.org/article/66aad92b4f694e8eb652eb40ee06dae7
Autor:
Francesca Lazzara, Federica Conti, Chiara Bianca Maria Platania, Chiara M. Eandi, Filippo Drago, Claudio Bucolo
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Age-related macular degeneration (AMD) is a degenerative retinal disease and one of major causes of irreversible vision loss. AMD has been linked to several pathological factors, such as oxidative stress and inflammation. Moreover, Aβ (1–42) oligo
Externí odkaz:
https://doaj.org/article/5993f80cbbba4e4388f14a9be33dec41
Publikováno v:
Biomedicines, Vol 10, Iss 11, p 2710 (2022)
Pandemic infection secondary to coronavirus disease 2019 (COVID-19) had an important impact on the general population affecting not only respiratory tract but also many other organs. Ocular manifestations are quite common at the level of the anterior
Externí odkaz:
https://doaj.org/article/c97bba4bfa174353b7c57b83e031dc20
Publikováno v:
Medicina, Vol 58, Iss 9, p 1180 (2022)
Background and Objectives: Brolucizumab is a novel anti-vascular endothelial growth factor (VEGF), whose efficacy has been shown in the Hawk and Harrier phase 3 clinical studies. The goal of the present case series is to report initial results of bro
Externí odkaz:
https://doaj.org/article/ace74c6af22f4cea9600f54bd2dc4d6e
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
We report a case of central retinal artery occlusion (CRAO) in a patient with a previous history of severe COVID-19 disease. This disease has been associated with inflammatory-induced homeostasis changes leading to endothelial dysfunction and a proco
Externí odkaz:
https://doaj.org/article/6cc9287d0e0145a59c43cb845731736f
Autor:
Marco Rispoli, Chiara M. Eandi, Luca Di Antonio, Raphael Kilian, Andrea Montesel, Maria C. Savastano
Publikováno v:
Biomedicines, Vol 9, Iss 6, p 668 (2021)
Background: The purpose of this study was to describe early changes in the morphology of pigment epithelium detachments (PED) after an intravitreal injection of Brolucizumab into eyes with macular neovascularization secondary to exudative age-related
Externí odkaz:
https://doaj.org/article/7046ad96f0d74997b777ee3969736cbc